Halozyme(HALO) - 2024 Q4 - Earnings Call Transcript
Halozyme Therapeutics (HALO) Q4 2024 Earnings Call February 19, 2025 12:51 AM ET Company Participants Tram Bui - Vice President, Investor Relations & Corporate CommunicationHelen Torley - President & Chief Executive OfficerNicole LaBrosse - CFOMichael Difiore - Managing DirectorJason Butler - Managing Director & Biotechnology Equity Research Conference Call Participants Sean Laaman - AnalystBrendan Smith - Director - Senior AnalystMohit Bansal - AnalystJessica Fye - Managing Director & Equity Research Analy ...